Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Clinical Decision Support Systems Markets in North America and Europe provides a comprehensive analysis of the clinical decision support systems ( CDSS s) markets in North America and Europe and discusses the opportunities within these markets from 2010-2016. In this research, expert analysts thoroughly examine the following markets by region: Europe - the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Benelux and North America - the United States and Canada.

CDSS s are generally believed to support clinicians in making informed decisions and as such have the potential to influence the quality - the effectiveness, efficiency and economics - and, most importantly, the safety of healthcare. CDSS is useful for a variety of clinical activities such as preventive care, diagnostics, therapeutics, comprehensive disease management, image recognition and interpretation and prognostics. Theoretically, these systems can be used for any speciality of clinical care and in any setting, where the requisite knowledge base and technological infrastructure exist. The plasticity of this application suggests a diverse range of opportunities that influence the quality and safety of healthcare. Health services need to find new, more cost-effective ways of delivering care due to the serious financial and resource implications of ageing populations, improved survival from a range of acute and long-term disorders, and the ever increasing array of treatment options now available. Major national efforts are underway world-wide to promote the widespread and effective use of tools such as the electronic medical record and computerised physician order entry systems.

Although computerising clinical data and transactions can substantially develop information management in patient care, CDSS reaches its full potential only when the relevant clinical knowledge is combined with the data to take informed healthcare decisions and actions. Furthermore, CDSS is proven effective in improving the outcomes at several state-of-the-art healthcare institutions by reducing adverse drug events, medication-related errors and costs by millions of dollars per year even within single hospitals. If these results are scaled up to a regional and national level, CDSS s have the potential to save thousands of lives and billions of dollars each year.

A major factor limiting the full adoption and impact of CDSS is the lack of a common and transportable base of clinical knowledge and clinical decision support interventions that can be easily and widely used in electronic health records and other clinical information systems . Clinical knowledge and decision support interventions for use in clinical information systems can currently be obtained from a variety of sources whose formats are non-standard and accessibility is variable - healthcare IT vendor's shared libraries, commercial decision support content publishers, and the Internet. Largely, non-standardised and independent approaches to creating and presenting clinical knowledge and interventions severely limit incorporation, re-usability and interoperability in clinical information systems, presenting a major challenge for the CDSS market participants.

Furthermore, clinicians sometimes resist the use of CDSSs, as they fear that these will reduce autonomy or increase liability. Several organisations do not recognise a clear business case for financial and organisational investments in developing and executing a plan to optimise CDSSs. Vendors of CDSSs should collaborate with policy makers to address these issues. Similar to other health care information technologies , the costs associated with CDSS implementation are primarily borne by healthcare organisations while many of the benefits accrue to patients, payers and the society as a whole in terms of improved healthcare. Supportive policies and new financial incentives will help to redress these deficiencies and facilitate adoption of CDSS tools more swiftly and broadly.

Source: Companiesandmarkets.com